心不全における低アルブミニア: 病理生理学,臨床的影響,管理戦略
Mohamad Ghazal1, Wissam I Khalife2
1Department of Medicine, Albany Medical Center, Albany, NY, USA. ghazalm@amc.edu.
Heart failure reviews
|September 6, 2025
まとめ
心不全における低アルブミニアは結果を悪化させる. アルブミンの注入は重度の腫れがある患者の選択に役立ちますが,日常的な使用は推奨されません.
科学分野:
- 心臓病科
- 腎臓科
- 内科 医学
背景:
- 心不全 (HF) の患者では低アルブミニアが多く,有害な結果と相関しています.
- 病理生理学的要因には,栄養不良,肝臓の詰まり,炎症,タンパク質喪失性腸病などがあります.
- 低アルブミンは,オンコティック・プレッシャーを低下させ,HFの症状と肺腫を悪化させる.
研究 の 目的:
- HFにおける低albuminemiaの病理生理学をレビューする.
- HFの管理におけるアルブミン注入の証拠を評価する.
主な方法:
- 心不全における低albuminemiaに関する研究の文献レビュー.
- アルブミン療法に関する病理学的メカニズムと臨床試験のデータ分析
主要な成果:
- アルブミン補給は尿路を促すことができるが,その全体的な有効性は議論されている.
- アルブミンの日常的な使用は,HF患者のアウトカムを改善しません.
- 重度の低アルブミン血症による耐火性腫/アシテスの選択的使用は検討できる.
結論:
- 口腔栄養は栄養不良のHF患者で改善されます.
- 静脈内アルブミン療法には,HFの管理に関する明確なガイドラインがない.
- 特定のHF集団におけるアルブミン注入の役割を明らかにするためにさらなる研究が必要である.
関連する概念動画
Heart Failure II: Pathophysiology
33
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
33
Heart Failure VI: Adjunct Therapies
27
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
27
Heart Failure VII: Nursing Interventions
139
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
139
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure V: Medical Management
23
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure I: Introduction
49
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
49


